806. Deputy Pat Buckley asked the Minister for Health for greater clarity and urgency in addressing access to approved cancer medications in Ireland; and if she will make a statement on the matter. [27704/25]
Parliamentary questions
Questions
TDs ask ministers questions to get answers on the record, most of them in writing. Here is every one asked in the 34th Dáil, by the department it went to and the subject heading it was filed under. How questions work
Browse the questions
Showing questions under the heading Medicinal Products.
1,228 questions match, newest first.
167. Deputy George Lawlor asked the Minister for Health if she will address the ongoing shortage of estradot (estradiol transdermal) patches in Ireland; if she is aware that women are frequently having to change pharmacies, travel to Northern Ireland, or arrange private courier services to access their prescribed hormone replacement therapy (HRT); if she will comment on reports that general practitioners are reluctan…
184. Deputy Sorca Clarke asked the Minister for Health for an update on the review of atropine 0.01%; if consideration has been given to making it available for myopia control; and if she will make a statement on the matter. [26316/25]
185. Deputy Sorca Clarke asked the Minister for Health the criteria for which atropine 0.01% eye drops, prescribed for myopia, to limit the risk of damage to eyes and potentially detached retinas is not on licence, and therefore not covered by the drug payment scheme. [26317/25]
189. Deputy Duncan Smith asked the Minister for Health if there are any proposals to include Venlafaxine in the free HRT scheme, given this is commonly prescribed for women who cannot take HRT due to previous cancer, as this medication is an alternative prescribed for the many women unable to take HRT; and if she will make a statement on the matter. [26372/25]
782. Deputy Paul Murphy asked the Minister for Health if she is aware of the fact that a number of new medicines are being made available through private healthcare providers, while public patients are made to wait for these to become available (details supplied); if she will instruct her Department to ensure that lifesaving medication is made available to all patients; and if she will make a statement on the matter.…
787. Deputy Brian Stanley asked the Minister for Health if there are any plans to add Ozempic and Saxenda to the list of medications available under the drugs payment scheme for weight loss programmes; and if she will make a statement on the matter. [25199/25]
788. Deputy James Geoghegan asked the Minister for Health to examine concerns in correspondence (details supplied) and outline the measures she is taking to address these. [25210/25]
789. Deputy James Geoghegan asked the Minister for Health for an update on her engagements with representatives of pharmacists in relation to the free HRT scheme; if she will consider raising the dispensing fee for each HRT item (details supplied); and if she will make a statement on the matter. [25211/25]
791. Deputy John Lahart asked the Minister for Health further to Parliamentary Question No. 235 of 2 October 2024, her views on whether funding earmarked for new medicines was spent on existing medicines; whether she will issue a directive to the HSE to ensure all funding earmarked for new medicines is spent exclusively for that purpose; and if she will make a statement on the matter. [25228/25]
806. Deputy David Cullinane asked the Minister for Health the number of community pharmacies that have signed up to the upcoming HRT programme proposed by her Department, by county of those who have done so. [25303/25]
808. Deputy Michael Collins asked the Minister for Health further to Parliamentary Question No. 798 of 18 February 2025, for a further update on the progression of the recommended policy regarding 'controlled drugs' Ava's protocol, as per the inquest on 5 December 2024; and if she will make a statement on the matter. [25333/25]
814. Deputy Seán Ó Fearghaíl asked the Minister for Health further to Parliamentary Question No. 177 of 18 May 2022, when voretigene neparvovec luxturna will be added to the reimbursement list in line with the Health Act 2013 and the national framework agreed with the pharmaceutical industry under which a company must submit an application to the HSE to have a new medicine approved; and if she will make a statement o…
828. Deputy Pádraig O'Sullivan asked the Minister for Health if he will make the freestyle libre 2 system available on medical card to those using both metformin and insulin; and if she will make a statement on the matter. [25471/25]
309. Deputy Niamh Smyth asked the Minister for Health if she will review correspondence (details supplied) in relation to the proposed HRT scheme; and if she will make a statement on the matter. [24913/25]
325. Deputy Claire Kerrane asked the Minister for Health further to Parliamentary Question No. 2211 of 29 April 2025, if a timeline or target exists for the provision of intravitreal injections for macular degeneration in a community setting; the specific steps which have been taken to date in actioning this recommendation from the 2018 Eye Services Review; and if she will make a statement on the matter. [24973/25]
328. Deputy John Lahart asked the Minister for Health to outline the position with regard to access to medicines by pharmacists, as indicated at a recent conference; if she is satisfied with the supply chain for all drugs; and if she will make a statement on the matter. [25002/25]
189. Deputy Jennifer Whitmore asked the Minister for Health the number of community pharmacies she has written to regarding the provision of free HRT; the uptake she has had on her offer to date, on a county-by-county basis, in tabular form; and if she will make a statement on the matter. [24629/25]
190. Deputy Jennifer Whitmore asked the Minister for Health whether her Department has provided pharmacists with a full list of medications to be covered under the free HRT scheme; and if she will make a statement on the matter. [24630/25]
191. Deputy Jennifer Whitmore asked the Minister for Health whether appropriate IT systems are in place to allow for the free HRT scheme to be rolled out efficiently, and for individual pharmacies to be reimbursed by the State in a timely manner; and if she will make a statement on the matter. [24631/25]
192. Deputy Jennifer Whitmore asked the Minister for Health if the free HRT scheme will have any impact on recipients of the drug payment scheme, in particular in instances where their selected pharmacy is not signed up to the free HRT scheme; and if she will make a statement on the matter. [24632/25]
194. Deputy Michael Cahill asked the Minister for Health the strategies in place to ensure the continuous supply of prescription drugs to pharmacies throughout the country (details supplied); and if she will make a statement on the matter. [24664/25]
113. Deputy Marie Sherlock asked the Minister for Health the action she has taken to ensure that community pharmacists will administer the free hormone replacement therapy, HRT, scheme from 1 June 2025; and if she will make a statement on the matter. [24511/25]
130. Deputy Pádraig O'Sullivan asked the Minister for Health the progress made regarding commitments in the Programme for Government surrounding rare diseases and specifically plans for a review of the drug reimbursement process, increasing the number of clinical trials and providing an early access scheme for new drug and treatment; and if she will make a statement on the matter. [23511/25]
175. Deputy Michael Cahill asked the Minister for Health if Pluvicto, the new, life-changing prostate cancer medication that has been approved by the European Medicines Agency, will be made available to all public patients at the earliest possible date; the estimated full year cost of providing this treatment; and if she will make a statement on the matter. [23673/25]